Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BRC-OA (Britecyte, Inc.)
- Development stage
- Unknown
- Lead developer
- Britecyte
- Administration
- Injection, Implantation, Intralesional Injection, Subcutaneous Injection, Soft Tissue Injection
01
Overview
BRC-OA is a cryopreserved, devitalized human adipose tissue allograft developed by Britecyte for the treatment of pain associated with osteoarthritis of the knee. The product is composed of a devitalized human adipose particulate that retains the inherent structural and biochemical properties of native adipose tissue, including the extracellular matrix (ECM) and various signaling molecules. By providing a biological scaffold and potentially modulating the inflammatory environment within the joint, BRC-OA aims to alleviate pain and improve function in patients with mild to severe osteoarthritis. It is administered via intra-articular injection and is currently being evaluated in Phase 1/2 clinical trials.
- Brand names
- Liposana
- Other names
- cryopreserved devitalized adipose tissue allograftdevitalized human adipose particulate
Beyond the preview
Go deeper on BRC-OA (Britecyte, Inc.).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BRC-OA (Britecyte, Inc.).